Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in alzheimer's disease

Archives of Neurology

Volumn 52, Issue 3, 1995, Pages 257-262

  Wolfe, Nicola ^a   Reed, Bruce R ^a   Eberling, Jamie L ^b   Jagust, William J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IOFETAMINE I 123;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CORRELATION FUNCTION; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE;

AGED; ALZHEIMER DISEASE; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; FEMALE; HUMAN; MALE; MEMORY; SUPPORT, U.S. GOV'T, P.H.S.; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0028945195     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1995.00540270049018     Document Type: Article

References (53)

1. Stern Y, Mayeux R, Sano M, Hauser WA, Bush T. Predictors of disease course in patients with probable Alzheimer's disease. Neurology. 1987;37:1649-1653.
2. Stern Y, Hesdorffer D, Sano M, Mayeux R. Measurement and prediction of functional capacity in Alzheimer's disease. Neurology. 1990;40:8-14.
3. Chen J-Y, Stern Y, Sano M, Mayeux R. Cumulative risks of developing extra-pyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. Arch Neurol. 1991;48:1141-1143.
4. Reisberg B, Ferris SH, Franssen E, Jenkins EC, Wisniewski K. Clinical features of a neuropathologically verified familial Alzheimer's cohort with onset in the fourth decade: comparison with senile onset Alzheimer's disease and etiopathogenic implications. Prog Clin Biol Res. 1989;317:43-54.
5. Rosen J, Zubenko GS. Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease. Biol Psychiatry. 1991;29:224-232.
6. Drevets WC, Rubin EH. Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer's type. Biol Psychiatry. 1989;25:39-48.
7. Miller TP, Tinklenberg JR, Brooks JO, Yesavage JA. Cognitive decline in patients with Alzheimer disease: differences in patients with and without extra-pyramidal signs. Alzheimer Dis Assoc Disord. 1991;5:251-256.
8. Lucca U, Comelli M, Tettamanti M, Tiraboschi P, Spagnoli A. Rate of progression and prognostic factors in Alzheimer's disease: a prospective study. J Am Geriatr Soc. 1993;41:41-49.
9. Mortimer J, Ebbitt B, Jun S-P, Finch M. Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology. 1992; 42:1689-1696.
10. Katzman R, Brown T, Thal LJ, et al. Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease. Ann Neurol. 1988;24:384-389.
11. Kramer-Ginsberg E, Mohs R, Aryan M, Lobel D, Davidson M, Davis K. Clinical predictors of course for Alzheimer's patients in a longitudinal study: a preliminary report. Psychopharmacol Bull. 1988;24:458-462.
12. Drachman DA, O'Donnell BF, Lew RA, Swerer JM. The prognosis of Alzheimer's disease: 'how far' rather than 'how fast' best predicts the course. Arch Neurol. 1990;47:851-856.
13. Boller F, Becker J, Holland A, Forbes M, Hood P, McGonigle-Gibson K. Predictors of decline in Alzheimer's disease. Cortex. 1991;27:9-17.
14. Teng E, Chui H, Schneider L, Metzger L. Alzheimer's dementia: performance on the Mini-Mental State Examination. J Consult Clin Psychol. 1987;55:96-100.
15. Burns A, Jacoby R, Levy R. Progression of cognitive impairment in Alzheimer's disease. J Am Geriatr Soc. 1991;39:39-45.
16. Ortof E, Crystal HA. Rate of progression of Alzheimer's disease. J Am Geriatr Soc. 1989;37:511-514.
17. Friedland RP, Brun A, Budinger TF. Pathological and positron emission tomographic correlations in Alzheimer's disease. Lancet. 1985;1:228.
18. Jagust WJ, Budinger TF, Reed BR. The diagnosis of dementia with single photon emission computed tomography. Arch Neurol. 1987;44:258-262.
19. Johnson KA, Mueller ST, Walshe TM, English RJ, Holman BL. Cerebral perfusion imaging in Alzheimer's disease: use of single photon emission computed tomography and iofetamine hydrochloride I 123. Arch Neurol. 1987;44:165-168.
20. Eberling JL, Jagust WJ, Reed BR, Baker MG. Reduced temporal lobe blood flow in Alzheimer's disease. Neurobiol Aging. 1992;13:483-491.
21. Haxby JV, Grady CL, Duara R, Schlageter N, Berg G, Rapoport SI. Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's type dementia. Arch Neurol. 1986;43:882-885.
22. Grady CL, Haxby JV, Horwitz B, et al. Longitudinal study of early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol. 1988:10:576-596.
23. Haxby JV, Grady CL, Koss E, et al. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol. 1990;47:753-760.
24. Smith GS, deLeon MJ, George AE, et al. Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease: pathophysiologic implications. Arch Neurol. 1992;49:1142-1150.
25. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
26. Jagust WJ, Reed BR, Seab JP, Budinger TF. Alzheimer's disease: age at onset and SPECT patterns of regional cerebral blood flow. Arch Neurol. 1990;47:628-633.
27. Matsui T, Hirano A. An Atlas of the Human Brain for Computerized Tomography. New York, NY: Igaku-Shoin Medical Publishers Inc; 1978.
28. Montaldi D, Brooks DN, McColl JH, et al. Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1990;53:33-38.
29. Duara R, Grady C, Haxby J, et al. Positron emission tomography in Alzheimer's disease. Neurology. 1986;36:879-887.
30. Brun A, Englund E. Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading. Histopathology. 1981;5:549-564.
31. Jagust WJ, Reed BR, Martin EM, Eberling JL, Nelson-Abbott RA. Cognitive function and regional cerebral blood flow in Parkinson's disease. Brain. 1992; 115:521-537.
32. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
33. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test Manual (Research Edition). San Antonio, Tex: Psychological Corp; 1987.
34. Benton AL, Hamsher K. Multilingual Aphasia Examination (Revised). Iowa City, Iowa: University of Iowa Press; 1983.
35. Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia, Pa: Lea & Febiger; 1983.
36. Wechsler D. Wechsler Adult Intelligence Scale—Revised. New York, NY: Psychological Corp; 1981.
37. Moss MB, Albert MS, Butters Payne M. Differential pattern of memory loss among patients with Alzheimer's disease and Korsakoff syndrome. Arch Neurol. 1986;43:239-246.
38. Eberling JL, Reed BR, Baker MG, Jagust WJ. Cognitive correlates of regional cerebral blood flow in Alzheimer's disease. Arch Neurol. 1993;50:761-766.
39. Salmon D, Thai LJ, Butters N, Heindel WC. Longitudinal evaluation of dementia of the Alzheimer's type: a comparison of three standardized mental status examinations. Neurology. 1990;40:1225-1230.
40. Jagust WJ, Reed BR, Seab JP, Kramer JH, Budinger TF. Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia. Am J Physiol Imaging. 1989;4:89-96.
41. Reed BR, Jagust WJ, Seab JP, Ober BA. Memory and regional cerebral blood flow in mildly symptomatic Alzheimer's disease. Neurology. 1989;39:1537-1539.
42. Burns A, Philpot MP, Costa DC, EII PJ, Levy R. The investigation of Alzheimer's disease with single photon emission tomography. J Neurol Neurosurg Psychiatry. 1989;52:248-253.
43. Miller JD, de Leon MJ, Ferris SH, et al. Abnormal temporal lobe response in Alzheimer's disease during cognitive processing as measured by 11 C-2-deoxy-D-glucose and PET. J Cereb Blood Flow Metab. 1987;7:248-251.
44. Welsh KA, Butters N, Hughs JP, Mohs RC, Heyman A. Detection and staging of dementia in Alzheimer's disease. Arch Neurol. 1992;49:448-452.
45. McGeer EG, Peppard RP, McGeer H, et al. 18 Fluorodeoxyglucose positron emission tomography studies in presumed Alzheimer's cases, including 13 serial scans. Can J Neurol Sci. 1990;17:1-11.
46. Mishkin M. Memory in monkeys severely impaired by combined but not separate removal of amygdala and hippocampus. Nature. 1978;273:297-298.
47. Brady DR, Mufson EJ. Amygdaloid pathology in Alzheimer's disease: qualitative and quantitative analysis. Dementia. 1990;1:5-17.
48. Hyman BT, Van Hoesen GW, Damasio AR. Memory related neural systems in Alzheimer's disease: an anatomic study. Neurology. 1990;40:1721-1730.
49. Agid Y, Ruberg M, Dubois B, Pillon B. Anatomoclinical and biochemical concepts of subcortical dementia. In: Stahl SM, Iversen SD, Goodman EC, eds. Cognitive Neurochemistry. New York, NY: Oxford University Press Inc; 1987:248-271.
50. Peppard RF, Martin WRW, Carr GD, et al. Cerebral glucose metabolism in Parkinson's disease with and without dementia. Arch Neurol. 1992;49:1262-1268.
51. Morris JC, Edland S, Clark C, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), IV: rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology. 1993;43:2457-2465.
52. Haxby JV, Raffaele K, Gillette J, Schapiro MB. Rapoport SI. Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type. J Clin Exp Neuropsychol. 1992;4:575-592.
53. Bennett DA, Gilley DW, Wilson RS, Sullivan M, Fox JH. Rate of cognitive decline in Binswanger's disease vs Alzheimer's disease with and without white matter lesions. Ann Neurol. 1991;30:250.